Molecular epidemiology

Last updated

Molecular epidemiology is a branch of epidemiology and medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations. [1] This field has emerged from the integration of molecular biology into traditional epidemiological research. Molecular epidemiology improves our understanding of the pathogenesis of disease by identifying specific pathways, molecules and genes that influence the risk of developing disease. [2] [3] More broadly, it seeks to establish understanding of how the interactions between genetic traits and environmental exposures result in disease. [4]

Contents

History

The term "molecular epidemiology" was first coined by Edwin D. Kilbourne in a 1973 article entitled "The molecular epidemiology of influenza". [5] The term became more formalized with the formulation of the first book on molecular epidemiology titled Molecular Epidemiology: Principles and Practice by Paul A. Schulte and Frederica Perera. [6] At the heart of this book is the impact of advances in molecular research that have given rise to and enabled the measurement and exploitation of the biomarker as a vital tool to link traditional molecular and epidemiological research strategies to understand the underlying mechanisms of disease in populations.[ citation needed ]

Modern use

While most molecular epidemiology studies are using conventional disease designation system for an outcome (with the use of exposures at the molecular level), compelling evidence indicates that disease evolution represents inherently heterogeneous process differing from person to person. Conceptually, each individual has a unique disease process different from any other individual ("the unique disease principle"), [7] considering uniqueness of the exposome and its unique influence on molecular pathologic process in each individual. Studies to examine the relationship between an exposure and molecular pathologic signature of disease (particularly, cancer) became increasingly common throughout the 2000s. However, the use of molecular pathology in epidemiology posed unique challenges including lack of standardized methodologies and guidelines as well as paucity of interdisciplinary experts and training programs. [8] [9] The use of "molecular epidemiology" for this type of research masked the presence of these challenges, and hindered the development of methods and guidelines. [10] [11] Furthermore, the concept of disease heterogeneity appears to conflict with the premise that individuals with the same disease name have similar etiologies and disease processes.

Analytical methods

The genome of a bacterial species fundamentally determines its identity. Thus, gel electrophoresis techniques like pulsed-field gel electrophoresis can be used in molecular epidemiology to comparatively analyze patterns of bacterial chromosomal fragments and to elucidate the genomic content of bacterial cells. Due to its widespread use and ability to analyse epidemiological information about most bacterial pathogens based on their molecular markers, pulsed-field gel electrophoresis is relied upon heavily in molecular epidemiological studies. [12]

Applications

Molecular epidemiology allows for an understanding of the molecular outcomes and implications of diet, lifestyle, and environmental exposure, particularly how these choices and exposures result in acquired genetic mutations and how these mutations are distributed throughout selected populations through the use of biomarkers and genetic information. Molecular epidemiological studies are able to provide additional understanding of previously-identified risk factors and disease mechanisms. [13] Specific applications include:

Criticism

While the use of advanced molecular analysis techniques within the field of molecular epidemiology is providing the larger field of epidemiology with greater means of analysis, Miquel Porta identified several challenges that the field of molecular epidemiology faces, particularly selecting and incorporating requisite applicable data in an unbiased manner. [15] Limitations of molecular epidemiological studies are similar in nature to those of generic epidemiological studies, that is, samples of convenience - both of the target population and genetic information, small sample sizes, inappropriate statistical methods, poor quality control, and poor definition of target populations. [16]

See also

Related Research Articles

<span class="mw-page-title-main">Epidemiology</span> Study of health and disease within a population

Epidemiology is the study and analysis of the distribution, patterns and determinants of health and disease conditions in a defined population.

The science of epidemiology has matured significantly from the times of Hippocrates, Semmelweis and John Snow. The techniques for gathering and analyzing epidemiological data vary depending on the type of disease being monitored but each study will have overarching similarities.

Pathogenesis is the process by which a disease or disorder develops. It can include factors which contribute not only to the onset of the disease or disorder, but also to its progression and maintenance. The word comes from Greek πάθος pathos 'suffering, disease' and γένεσις genesis 'creation'.

<span class="mw-page-title-main">Case–control study</span> Type of observational study comparing two existing groups differing in outcome

A case–control study is a type of observational study in which two existing groups differing in outcome are identified and compared on the basis of some supposed causal attribute. Case–control studies are often used to identify factors that may contribute to a medical condition by comparing subjects who have that condition/disease with patients who do not have the condition/disease but are otherwise similar. They require fewer resources but provide less evidence for causal inference than a randomized controlled trial. A case–control study is often used to produce an odds ratio, which is an inferior measure of strength of association compared to relative risk, but new statistical methods make it possible to use a case-control study to estimate relative risk, risk differences, and other quantities.

An environmental factor, ecological factor or eco factor is any factor, abiotic or biotic, that influences living organisms. Abiotic factors include ambient temperature, amount of sunlight, and pH of the water soil in which an organism lives. Biotic factors would include the availability of food organisms and the presence of biological specificity, competitors, predators, and parasites.

The Framingham Heart Study is a long-term, ongoing cardiovascular cohort study of residents of the city of Framingham, Massachusetts. The study began in 1948 with 5,209 adult subjects from Framingham, and is now on its third generation of participants. Prior to the study almost nothing was known about the epidemiology of hypertensive or arteriosclerotic cardiovascular disease. Much of the now-common knowledge concerning heart disease, such as the effects of diet, exercise, and common medications such as aspirin, is based on this longitudinal study. It is a project of the National Heart, Lung, and Blood Institute, in collaboration with Boston University. Various health professionals from the hospitals and universities of Greater Boston staff the project.

Multilocus sequence typing (MLST) is a technique in molecular biology for the typing of multiple loci, using DNA sequences of internal fragments of multiple housekeeping genes to characterize isolates of microbial species.

<span class="mw-page-title-main">Pulsed-field gel electrophoresis</span> Lab technique for separation of DNA

Pulsed field gel electrophoresis is a technique used for the separation of large DNA molecules by applying to a gel matrix an electric field that periodically changes direction. Pulsed-field gel electrophoresis (PFGE) is a method used to separate large segments of DNA using an alternating and cross field. In a uniform magnetic field, components larger than 50kb move through the gel in a zigzag pattern, allowing for more effective separation of DNA molecules. This method is commonly used in microbiology for typing bacteria and is a valuable tool for epidemiological studies and gene mapping in microbes and mammalian cells. It also played a role in the development of large-insert cloning systems such as bacterial and yeast artificial chromosomes.

Psychiatric epidemiology is a field which studies the causes (etiology) of mental disorders in society, as well as conceptualization and prevalence of mental illness. It is a subfield of the more general epidemiology. It has roots in sociological studies of the early 20th century. However, while sociological exposures are still widely studied in psychiatric epidemiology, the field has since expanded to the study of a wide area of environmental risk factors, such as major life events, as well as genetic exposures. Increasingly neuroscientific techniques like MRI are used to explore the mechanisms behind how exposures to risk factors may impact psychological problems and explore the neuroanatomical substrate underlying psychiatric disorders.

Molecular pathology is an emerging discipline within pathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology shares some aspects of practice with both anatomic pathology and clinical pathology, molecular biology, biochemistry, proteomics and genetics, and is sometimes considered a "crossover" discipline. It is multi-disciplinary in nature and focuses mainly on the sub-microscopic aspects of disease. A key consideration is that more accurate diagnosis is possible when the diagnosis is based on both the morphologic changes in tissues and on molecular testing.

While epidemiology is "the study of the distribution and determinants of states of health in populations", social epidemiology is "that branch of epidemiology concerned with the way that social structures, institutions, and relationships influence health." This research includes "both specific features of, and pathways by which, societal conditions affect health".

Genetic epidemiology is the study of the role of genetic factors in determining health and disease in families and in populations, and the interplay of such genetic factors with environmental factors. Genetic epidemiology seeks to derive a statistical and quantitative analysis of how genetics work in large groups.

Miquel Porta is a Catalan physician, epidemiologist and scholar. He has promoted the integration of biological, clinical and environmental knowledge and methods in health research and teaching, which he has conducted internationally; notably, in Spain, at the University of North Carolina at Chapel Hill, Harvard, Imperial College London, and several other universities in Europe, North America, Kuwait, and Brazil. Appointed by the International Epidemiological Association (IEA), in 2008 he succeeded the Canadian epidemiologist John M. Last as Editor of "A Dictionary of Epidemiology". In the Preface to this book he argues for an inclusive and integrative practice of the science of epidemiology.

David A. Savitz is a professor of Community Health in the Epidemiology Section of the Program in Public Health, Vice President for Research, and Professor of Obstetrics and Gynecology, at The Alpert Medical School of Brown University, and Associate Director for Perinatal Research in The Department of Obstetrics and Gynecology at Women & Infants Hospital, both in Providence, Rhode Island. Savitz is the author of Interpreting epidemiologic evidence: strategies for study design and analysis (ISBN 0-19-510840-X) and more than 275 peer-reviewed articles. He was elected to the Institute of Medicine in 2007.

<span class="mw-page-title-main">Nutritional epidemiology</span> Field of medical research on disease and diet

Nutritional epidemiology examines dietary and nutritional factors in relation to disease occurrence at a population level. Nutritional epidemiology is a relatively new field of medical research that studies the relationship between nutrition and health. It is a young discipline in epidemiology that is continuing to grow in relevance to present-day health concerns. Diet and physical activity are difficult to measure accurately, which may partly explain why nutrition has received less attention than other risk factors for disease in epidemiology. Nutritional epidemiology uses knowledge from nutritional science to aid in the understanding of human nutrition and the explanation of basic underlying mechanisms. Nutritional science information is also used in the development of nutritional epidemiological studies and interventions including clinical, case-control and cohort studies. Nutritional epidemiological methods have been developed to study the relationship between diet and disease. Findings from these studies impact public health as they guide the development of dietary recommendations including those tailored specifically for the prevention of certain diseases, conditions and cancers. It is argued by western researchers that nutritional epidemiology should be a core component in the training of all health and social service professions because of its increasing relevance and past successes in improving the health of the public worldwide. However, it is also argued that nutritional epidemiological studies yield unreliable findings as they rely on the role of diet in health and disease, which is known as an exposure that is susceptible to considerable measurement error.

<span class="mw-page-title-main">Exposome</span>

The exposome is a concept used to describe environmental exposures that an individual encounters throughout life, from conception to death. It encompasses both external and internal factors, including chemical, physical, biological, and social factors that may influence human health.

Molecular pathological epidemiology is a discipline combining epidemiology and pathology. It is defined as "epidemiology of molecular pathology and heterogeneity of disease". Pathology and epidemiology share the same goal of elucidating etiology of disease, and MPE aims to achieve this goal at molecular, individual and population levels. Typically, MPE utilizes tissue pathology resources and data within existing epidemiology studies. Molecular epidemiology broadly encompasses MPE and conventional-type molecular epidemiology with the use of traditional disease designation systems.

Shuji Ogino is a molecular pathological epidemiologist, pathologist, and epidemiologist. He is currently Professor of Pathology at Harvard Medical School and Brigham and Women's Hospital, and Professor in the Department of Epidemiology at Harvard T.H. Chan School of Public Health. He is also Chief of Program in MPE Molecular Pathological Epidemiology at Brigham and Women's Hospital, and an associate member of Broad Institute of MIT and Harvard. He has been known for his work on establishing a new discipline, molecular pathological epidemiology, which represents an interdisciplinary science of molecular pathology and epidemiology.

Occupational toxicology is the application of toxicology to chemical hazards in the workplace. It focuses on substances and conditions that occur in workplaces, where inhalation exposure and dermal exposure are most important, there is often exposure to mixtures of chemicals whose interactions are complex, health effects are influenced or confounded by other environmental and individual factors, and there is a focus on identifying early adverse affects that are more subtle than those presented in clinical medicine.

Paolo Vineis is an Italian professor of Environmental Epidemiology at Imperial College London. His main work is on the impact of environmental changes on human health and molecules. This includes the use of omics technologies in epidemiological studies, that is the quantitative measurement of global sets of molecules in biological samples using high-throughput techniques, in combination with advanced biostatistics and bioinformatics tools. In particular, the study of epigenomic changes in DNA is currently one of the most promising fields for the identification of long-term environmental fingerprints. The development of the concept of exposome, led to Professor Vineis being awarded a grant from the European Commission in 2012 on exposome research (EXPOsOMICS). The exposome refers to the totality of internal and external exposures which interact at a cellular and systems level to generate a metabolic/ molecular signature which can be used to gain new understanding of the transition from health to disease. Paolo Vineis is also the coordinator of the Horizon 2020 LIFEPATH project, whose aim is to understand the determinants of diverging ageing pathways among individuals belonging to different socio-economic groups. This is achieved by integrating social science approaches with biology, using omics measurements. Paolo Vineis is also the director of the Unit of Molecular and Genetic Epidemiology, Italian Institute of Genomic Medicine (IIGM), Turin, Italy. Professor Vineis has published many research articles on environmental risks and has written several books on health, causality and the ethics of health care.

References

  1. ↑ "What is Molecular Epidemiology?". Molecular Epidemiology Homepage. University of Pittsburgh. 28 July 1998. Retrieved 15 January 2010.
  2. ↑ "What is Molecular Epidemiology?". aacr.org. Archived from the original on 2008-03-03. Retrieved 2008-02-19.
  3. ↑ Miquel Porta, editor. Greenland S, Hernán M, dos Santos Silva I, Last JM, associate editors (2014). A dictionary of epidemiology , 6th. edition. New York: Oxford University Press. ISBN   9780199976737
  4. ↑ Porta, M. (2002). "Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences". J Epidemiol Community Health. 56 (10): 734–738. doi:10.1136/jech.56.10.734. PMC   1732039 . PMID   12239196.
  5. ↑ Kilbourne ED (Apr 1973). "The molecular epidemiology of influenza". J Infect Dis. 127 (4): 478–87. doi:10.1093/infdis/127.4.478. PMID   4121053.
  6. ↑ Schulte, Paul A.; Perera, Frederica P. (1993). Molecular Epidemiology: Principles and Practice. Academic Press. p. 588. ISBN   0-12-632346-1.
  7. ↑ Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt AJ, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013;26:465-484.
  8. ↑ Sherman ME, Howatt W, Blows FM, Pharoah P, Hewitt SM, Garcia-Closas M. Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev 2010;19(4):966-972.
  9. ↑ Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: Towards molecular and population-level health science. Am J Epidemiol 2012;176:659-667.
  10. ↑ Kuller LH. Invited commentary: the 21st century epidemiologist--a need for different training? Am J Epidemiol 2012;176(8):668-671.
  11. ↑ Ogino S, Beck AH, King EE, Sherman ME, Milner DA, Giovannucci E. Ogino et al. respond to "The 21st century epidemiologist". Am J Epidemiol 2012;176:672-674.
  12. ↑ Goering, R. (6 August 2010). "Pulsed field gel electrophoresis: A review of application and interpretation in the molecular epidemiology of infectious disease". Infection, Genetics and Evolution. 10 (7): 866–875. doi:10.1016/j.meegid.2010.07.023. PMID   20692376.
  13. ↑ Slattery, M. (2002). "The science and art of molecular epidemiology". J Epidemiol Community Health. 56 (10): 728–729. doi:10.1136/jech.56.10.728. PMC   1732025 . PMID   12239192.
  14. ↑ Field, N. (2014). "Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement" (PDF). Lancet Infect Dis. 14 (4): 341–352. doi:10.1016/S1473-3099(13)70324-4. PMID   24631223.
  15. ↑ Porta, M. (2002). "Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences". J Epidemiol Community Health. 56 (10): 734–738. doi:10.1136/jech.56.10.734. PMC   1732039 . PMID   12239196.
  16. ↑ Slattery, M. (2002). "The science and art of molecular epidemiology". J Epidemiol Community Health. 56 (10): 728–729. doi:10.1136/jech.56.10.728. PMC   1732025 . PMID   12239192.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.